The Story of the Six Deaths Among Participants in Pfizer’s Coronavirus Vaccine Trial



[ad_1]

The posts have circulated around 6 deaths of people who participated in the “BioNTech-Pfizer” vaccine trial for the emerging corona virus that causes Covid-19 disease, so what’s your story?

The vaccine was developed by the American company “Pfizer” and its partner, “BioNTech”, Germany. On Tuesday, the US Food and Drug Administration issued a report saying there were no safety concerns preventing it from obtaining an emergency use permit in the United States.

The results, which were published on the U.S. Food and Drug Administration website, echoed previously disclosed data from Pfizer, which showed that the vaccine was 95% effective in preventing symptoms of Covid-19, the disease caused by coronavirus.

Here we present 4 questions to uncover the six deaths:

1- How many people have participated in the Pfizer vaccine trial?

About 44 thousand.

2- Have 6 people who participated in the Pfizer vaccine trial died?

The answer is yes. 4 people died in the placebo group. And 2 died in the vaccinated group.

3- What is the cause of the two deaths in the vaccinated group?

The two who died in the vaccine group were over 55 years old. One died of cardiac arrest 62 days after vaccination and the other was due to arteriosclerosis, a condition in which blood vessels hardened with age, 3 days after vaccination.

4- Did the deaths occur from the vaccine?

The answer is no, as the US Food and Drug Administration report said, “All deaths represent accidents that occur in the general population of age groups at a similar rate.”

This means that the mortality rate is not higher than that of the population, that is, other people who have not received the vaccine. Therefore, these two deaths are not related, according to the report and the available scientific data, to receiving the Corona virus vaccine.

So don’t panic or be afraid. Yes, 6 died, but 4 did not get the vaccine in the first place. The other two deaths occurred for clear reasons unrelated to the vaccine and to similar proportions in the population.

On the other hand, employees of the US Food and Drug Administration said there is not enough data on children under 16 to determine if the vaccine will work in children. The data is also insufficient to make decisions about pregnant or lactating women or people with immunodeficiency, according to a Bloomberg report.

Messenger RNA

The Pfizer-Biontech vaccine involves injecting the body with genetic material known as “messenger RNA” or “messenger RNA,” which is a molecule that tells cells what to do.

And the messenger RNA, which controls this mechanism, is introduced to make a specific antigen for the Corona virus known as the Corona virus “spike”, which is a very distinctive tip present on its surface and that allows it to adhere to human cells to penetrate it. . This “thorn” will then be detected by the immune system, which will produce the antibodies, and these antibodies will remain for a certain period of time.

Pfizer applied for an emergency authorization in the United States on November 20. UK regulators approved the vaccine earlier this month, and on Tuesday, the British National Health Service launched an ambitious vaccination campaign that will start with tens of thousands of people over the age of 80.

And if the Pfizer vaccine is approved by the US Food and Drug Administration, it can begin shipping within 24 hours, according to officials in the administration of outgoing US President Donald Trump.



[ad_2]